Loading
Latest filing published 18 Aug 2017 for Cardiome Pharma Corp..
No signal scores available.
Richard Glickman discloses dealings in Cardiome Pharma Corp. to SEDI. Between 11 December 2006 and 15 August 2017, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 18 August 2017, the filings show a transaction in Cardiome Pharma Corp. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations